SUPN
Supernus Pharmaceuticals Inc
Price:  
30.24 
USD
Volume:  
375,040.00
United States | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

SUPN Relative Valuation

-95.5%
Upside

As of 2024-04-13, the Relative Valuation of Supernus Pharmaceuticals Inc (SUPN) is 1.36 USD. This relative valuation is based on P/E multiples. With the latest stock price at 30.24 USD, the upside of Supernus Pharmaceuticals Inc based on Relative Valuation is -95.5%.

The range of the Relative Valuation is 0.45 - 2.23 USD.

Range Selected
Trailing P/E multiples 19.3x - 31.7x 26.3x
Forward P/E multiples 17.7x - 22.1x 20.8x
Fair Price 0.45 - 2.23 1.36
Upside -98.5% - -92.6% -95.5%
30.24 USD
Stock Price
1.36 USD
Fair Price

SUPN Relative Valuation - Historical P/E Data

Date P/E
2024-04-12 1,298.07
2024-04-11 1,373.62
2024-04-10 1,366.75
2024-04-09 1,362.03
2024-04-08 1,349.15
2024-04-05 1,440.15
2024-04-04 1,426.84
2024-04-03 1,453.03
2024-04-02 1,423.84
2024-04-01 1,438.86
2024-03-28 1,464.19
2024-03-27 1,448.31
2024-03-26 1,394.22
2024-03-25 1,405.81
2024-03-22 1,481.79
2024-03-21 1,509.69
2024-03-20 1,497.24
2024-03-19 1,508.83
2024-03-18 1,467.62
2024-03-15 1,415.68
2024-03-14 1,432.42
2024-03-13 1,487.80
2024-03-12 1,413.11
2024-03-11 1,392.07
2024-03-08 1,333.69
2024-03-07 1,322.53
2024-03-06 1,335.41
2024-03-05 1,302.79
2024-03-04 1,314.81
2024-03-01 1,331.12
2024-02-29 1,274.89
2024-02-28 1,334.12
2024-02-27 1,317.38
2024-02-26 1,266.30
2024-02-23 1,247.41
2024-02-22 1,199.12
2024-02-21 1,207.92
2024-02-20 1,204.06
2024-02-16 1,219.94
2024-02-15 1,230.24
2024-02-14 1,183.03
2024-02-13 1,163.71
2024-02-12 1,216.94
2024-02-09 1,198.05
2024-02-08 1,197.62
2024-02-07 1,169.29
2024-02-06 1,215.22
2024-02-05 1,172.30
2024-02-02 1,187.75
2024-02-01 1,195.90